Finally, the first successfully performed murine xenografts specified their CD34+ CD38- CD90+ CD45RA- phenotype, whether derived from patients with low-risk MDS (LR-MDS) [isolated del(5q)] (10) or high-risk MDS (HR-MDS) (monosomy 7) (11). This evidence concerns the gene CD38 and myelodysplastic syndrome.